Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor
- PMID: 8530637
- DOI: 10.1210/jcem.80.12.8530637
Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor
Abstract
In order to account for the effects of insulin on the polycystic ovary (PCO), despite peripheral insulin resistance in women with polycystic ovary syndrome (PCOS), it has been suggested that insulin may act through the type-I insulin-like growth factor (IGF) receptor and not the insulin receptor. We have tested this hypothesis by investigating the effect of anti-insulin receptor and anti-type-I IGF receptor antibodies on insulin-stimulated steroidogenesis in human granulosa cells in vitro from normal (N) and PCO. Insulin-stimulated estradiol and progesterone production was inhibited by an anti-insulin receptor antibody. In contrast, anti-type-I IGF receptor antibodies had no effect on insulin-stimulated steroidogenesis in granulosa cell cultures from N or PCO. Hence insulin acts via its own receptor in human granulosa cells from both N and PCO.
Similar articles
-
The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries.J Clin Endocrinol Metab. 1990 Apr;70(4):894-902. doi: 10.1210/jcem-70-4-894. J Clin Endocrinol Metab. 1990. PMID: 2108185
-
Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries.J Clin Endocrinol Metab. 1996 Jan;81(1):302-9. doi: 10.1210/jcem.81.1.8550768. J Clin Endocrinol Metab. 1996. PMID: 8550768
-
Insulin-like growth factor-I (IGF-I) inhibits production of IGF-binding protein-1 while stimulating estradiol secretion in granulosa cells from normal and polycystic human ovaries.J Clin Endocrinol Metab. 1993 May;76(5):1275-9. doi: 10.1210/jcem.76.5.7684393. J Clin Endocrinol Metab. 1993. PMID: 7684393
-
Insulin action in the normal and polycystic ovary.Endocrinol Metab Clin North Am. 1999 Jun;28(2):361-78. doi: 10.1016/s0889-8529(05)70074-8. Endocrinol Metab Clin North Am. 1999. PMID: 10352923 Review.
-
Steroidogenesis in human polycystic ovary.Endocrinol Metab Clin North Am. 1988 Dec;17(4):751-69. Endocrinol Metab Clin North Am. 1988. PMID: 3143567 Review.
Cited by
-
Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.J Endocrinol Invest. 2013 Jul-Aug;36(7):478-84. doi: 10.3275/8771. Epub 2012 Nov 27. J Endocrinol Invest. 2013. PMID: 23211631
-
Inflammation mediates the effect of adiposity and lipid metabolism indicators on the embryogenesis of PCOS women undergoing in vitro fertilization/intracytoplasmic sperm injection.Front Endocrinol (Lausanne). 2023 Jul 25;14:1198602. doi: 10.3389/fendo.2023.1198602. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37560312 Free PMC article.
-
A novel action of insulin sensitizing drug as a potential promotor of preovulatory follicles, ovulation rate and prolificacy in sheep.Vet Res Commun. 2024 Apr;48(2):849-863. doi: 10.1007/s11259-023-10259-y. Epub 2023 Nov 14. Vet Res Commun. 2024. PMID: 37957451
-
Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS).Steroids. 2012 Mar 10;77(4):317-22. doi: 10.1016/j.steroids.2011.12.005. Epub 2011 Dec 8. Steroids. 2012. PMID: 22178785 Free PMC article.
-
Multiple signal transduction pathways regulate ovarian steroidogenesis.Rev Endocr Metab Disord. 2002 Jan;3(1):33-46. doi: 10.1023/a:1012748718150. Rev Endocr Metab Disord. 2002. PMID: 11883103 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical